Niels Wheeler

Innovation Activation Manager @ JLABS EMEA - My views are my own

[Niels Wheeler @NielsWheeler]

Calling the next generation of start-up CEOs! Interested in transforming your scientific innovation into a thriving biotech venture? Join a stellar line-up of speakers (and me) in Amsterdam! #mycompany

[Johnson & Johnson Innovation @JNJInnovation]

Join us in Amsterdam or virtually on 31 Oct for "Building a Biotech: Launching and Growing Your Start-up Company." Gain insights from J&J experts and guest speakers on funding, R&D, and more. Don’t miss out–register now: https://t.co/Td3LplaArS

[Niels Wheeler @NielsWheeler]

So much of healthcare today is about connecting with the right stakeholders at the right time.

Erik will be a keynote speaker during next week's JLABS program focused on the strategic use of Target Product Profiles.

#mycompany

[JLABS @JLABS]

During drug discovery and development, it is vital to already consider how your product might benefit patients. Read about the importance of ascertaining early how to add value in the future marketplace. https://t.co/LT8ony2Rjp

[Niels Wheeler @NielsWheeler]

Interested in a collaboration with J&J? Join this program to learn more about the due diligence process. #mycompany

[JLABS @JLABS]

Does the due diligence process seem daunting?

Don’t miss this chance to get insights from industry experts on how to and set your start-up up for collaboration success!

Register through: https://t.co/m8Un9i8IuI
#JNJInnovation #JLABS #JJIEvent

[Niels Wheeler @NielsWheeler]

Entrepreneurs and innovators are invited for an in-depth look into different aspects in the journey towards filing a #clinicaltrial application for large molecules. Will you join us in Leiden? #mycompany

[JLABS @JLABS]

Calling all #biotech startups! Join us for a program designed to guide you through the complexities of first-in-human trials for biologics. Gain insights from J&J experts on Preclinical Development, CMC, Trial Design, & Regulatory Strategies. Register: https://t.co/G3ENUdHIH8

[Niels Wheeler @NielsWheeler]

Interested in collaboration? This program discusses the role of IP in collaborations such as multi-component cellular therapies and vaccines. Will you join me in Leiden? #MyCompany

[JLABS @JLABS]

Your IP strategy may influence opportunities for collaboration. How do you balance the common good of the project with your own interests? Join the hybrid program as different stakeholders share their insights.

#Lifesciences #startups can register here: https://t.co/LI7eA2kFTP

[Niels Wheeler @NielsWheeler]

Today at the @I4Hevent Global Investor Forum in Rotterdam, Maria Van Dongen and I provided a workshop on Business Development Basics, during which I also introduced @jnjinnovation @JLABS. Are you interested to discuss collaboration? Let me know!
#mycompany #startups

[Niels Wheeler @NielsWheeler]

@springreizen is op zoek naar nieuwe #reisbegeleiders! Ik doe dat zelf al 12 jaar met veel plezier. Heb je ruime wandelervaring en zin in een nieuwe uitdaging? De deadline voor aanmelding is 7 januari. Check de site! https://t.co/G3PDacyk5L #wandelvakantie #hiking

[Niels Wheeler @NielsWheeler]

It was great to be at @NovioTechCampus to create this video. Nijmegen still feels a bit like home.

@Protinhi, thanks for being a part of this @jnjinnovation @JLABS initiative!

#mycompany @Briskr_

[Niels Wheeler @NielsWheeler]

Are you joining us in Leiden in two weeks' time? I believe this will be a very interesting discussion. #mycompany

[Niels Wheeler @NielsWheeler]

Onze oude woning in Lombok (Utrecht) is binnenkort te huur (nee, niet dat hutje op de foto ...). Er zit dan een nieuwe keuken in en de tuin (wel op de foto) blijft fantastisch. Geïnteresseerd!?

https://t.co/ukMFIzAcQh

[JLABS @JLABS]

#JLABS Global Head @melindarichter joins @NASDAQ Breakthrough Economy to discuss why inclusive access to capital is critical for life science innovation. Watch Melinda here: https://t.co/HXSWKHP0lf

[Johnson & Johnson Innovation @JNJInnovation]

We cultivate the European life sciences innovation ecosystem, aiming to enable entrepreneurs to create transformational healthcare solutions. To celebrate our collaborations, we’ve put the spotlight on our innovation network in EMEA.
See more: https://t.co/ho5qKdWoir

[Niels Wheeler @NielsWheeler]

Have you identified your long-term exit strategy? Learn more during this hybrid seminar. #mycompany

[JLABS @JLABS]

Join us on 19 May as @AllenOvery provides a no-nonsense guide to key aspects of exits through M&A, focused on #lifesciences and #medtech #startups.
In-person in Leiden or online: https://t.co/urcbng1DOe

[Niels Wheeler @NielsWheeler]

Building a stellar team can be a key ingredient of success next to your disruptive invention and fitting funding. #mycompany

[JLABS @JLABS]

Is your #lifesciences #startup looking to expand your team? Join the webinar on 3 March where different stakeholders will share insights in recruiting and retaining talent. https://t.co/eiuDSKC4hr #recruitment

[Niels Wheeler @NielsWheeler]

An organization will never change if the people don't change. To learn more I followed @Prosci training on change management. It was great to learn more about the people side of change. https://t.co/42ZZOVHUWj

[Niels Wheeler @NielsWheeler]

Great to see @UMCUtrecht from my home town as one of the IDEA #QuickFireChallenge awardees aiming to optimize AL Amyloidosis disease detection: https://t.co/61gpMCutBA #MyCompany

[Johnson & Johnson Innovation @JNJInnovation]

“Time. It’s the single most valuable gift healthcare providers can give their patients.”

Learn how the IDEA #QuickFireChallenge awardees aim to optimize detection of AL Amyloidosis for patients: https://t.co/DVWo3rQUJ3 @JanssenGlobal

[Johnson & Johnson Innovation @JNJInnovation]

The first release of Whole Genome Sequencing data for 200,000 @uk_biobank participants is now available. We expect the data will enable a better understanding of the genetic determinants of disease and contribute to accelerating drug discovery work: https://t.co/2drbppHGwE

[Johnson & Johnson Innovation @JNJInnovation]

Attention UK-based innovators! 🇬🇧 We are looking to connect with start-ups, entrepreneurs and researchers in the pharmaceutical, medical devices and consumer health fields. If this is you, tune in on 30 November to learn how we could work together. 👉 https://t.co/dgI9PKoTbR

[Niels Wheeler @NielsWheeler]

Excited for this program taking place on Thursday. It was inspiring to discuss the content with the speakers. #mycompany

[JLABS @JLABS]

Is your #startup considering the needs of patients, partners, prescribers and payers in the development of your healthcare innovation? Innovators are invited to join as we discuss commercial considerations in discovery and early development.

Register: https://t.co/hsP1HGrL1m

[Niels Wheeler @NielsWheeler]

Our webinar on EU grants is happening on Thursday. Do you want to about the experiences of startups in getting non-dilutive funding? Innovators are welcome to join. https://t.co/gcbimqpwvS #mycompany

[JLABS @JLABS]

For any #startup or small company, non-dilutive #funding may become an essential component of a healthy #financing mix.
Meet Bernd van Buuren from @protinhi and other speakers during this webinar & learn more!

🗓️ 14 October
⏰ 15:00-17:00 CEST
➡️ https://t.co/sgrLxnhEH0